Search
Close this search box.
Search
Close this search box.

August 3, 2023

Zenas BioPharma annonce la publication d’une étude de phase 2 sur l’obéxélimab, un traitement expérimental pour la maladie liée aux IgG4 (ML-IgG4), dans The Lancet Rheumatology

August 3, 2023

L’étude a montré que l’obéxélimab produisait une amélioration clinique rapide, forte et soutenue, y compris une rémission clinique complète, chez la plupart des patients atteints de ML-IgG4 active Les résultats soutiennent la poursuite du développement de l’obéxélimab pour le traitement de la ML-IgG4 et potentiellement d’autres maladies auto-immunes à médiation

Zenas BioPharma Publica Fase 2 do Estudo Clínico do Obexelimabe, um Tratamento Investigativo da Doença Relacionada à IgG4 (IgG4-RD), no The Lancet Rheumatology

August 3, 2023

Estudo revelou que o obexelimabe produziu melhora clínica rápida, forte e sustentada, incluindo remissão clínica completa, na maioria dos pacientes com IgG4-RD ativa Os resultados apoiam o desenvolvimento contínuo do obexelimabe para o tratamento de IgG4-RD e potencialmente outras condições autoimunes mediadas por células B WALTHAM, Mass., Aug. 02, 2023

Gobabis municipality owed N.dollars 61 million

August 3, 2023

The Gobabis municipality is owed N.dollars 61 million for water and electricity by residents, private companies and government agencies.This was revealed to Nampa by the town council’s spokesperson, Frederick Ueitele, in a recent interview.“The challen…

CPBN launches strategic business plan and website

August 3, 2023

The Central Procurement Board of Namibia (CPBN) on Wednesday launched its Integrated Strategic Business Plan (ISBP) for the period 2023/2024 – 2027/2028 in Windhoek.During the launching of the ISBP the CPBN also launched its new website, which will red…

RECENT POSTS >>

ADVERTISEMENT >>

CATEGORIES

POPULAR POSTS

PAGES

Copyright @ 2025 Eritrea Wire. All Right Reserved

Categories >>

RECENT POSTS >>